Searched for
EYECARE PRODUCTS
Titan Company shares gain 2%. Why JPMorgan, others see up to 28% upside after analyst call?Titan shares are seeing gains as brokerages maintain a positive outlook. The company has outlined ambitious growth plans for the coming yea...
Low cost glasses help India's poor see a better futureTofan Jena and Minati Rout are among many in India regaining sight through affordable glasses. GoodVision, a charity, offers free eye scree...
Titan shares surge 7%, hit fresh 52-week high on 35% YoY PAT growth, 46% income surgeTitan Company shares surged after strong Q4FY26 results, with 35% profit growth and 46% rise in income. Robust performance was led by jewel...
Titan Q4 Results: Cons profit jumps 35% YoY to Rs 1,179 crore; Rs 15/share dividend announcedTitan Q4 Results: Titan Company reported a robust 35% growth in net profit for Q4FY26, reaching Rs 1,179 crore, driven by a strong performa...
Titan shares soar 6% after better-than-expected Q4 business update. Should you buy?Titan Company shares surged 6% after reporting a 42% YoY jump in domestic business and a 156% YoY surge in international business for Q4 FY...
Titan Q3 update: Consumer business grows 40% YoY; company adds 56 new storesTitan Company's consumer businesses surged 40% year-on-year in Q3FY26, with international and domestic segments growing 79% and 38% respect...
Lupin ties up with Scope Opthalmics to market eyecare products in MexicoDrug maker Lupin has signed a distribution agreement with Ireland-based Scope Ophthalmics to market the Optase range of eye care products i...
Titan Q3 Update: Combined sales rise 12% YoY on strong consumer demandContinuing the network expansion, the retail presence stands at 2,362 stores at the end of the quarter
Titan sees 18% sales growth in September quarter; adds 105 new storesAbout the outlook for the festive season, the company said it continues to be "optimistic and is visible in positive consumer sentiment" ac...
Buy Titan Company, target price Rs 2,900: Sharekhan by BNP ParibasTitan Company’s (Titan’s) management outlined ambitious growth outlook for the company in the next five years at its analyst conference hel...
Lenskart earmarks USD 3 million to invest in 'eye-tech' startupAs part of this strategy, the Ratan Tata-backed firm has invested USD 500,000 (about Rs 3.3 crore) in US-based ThinOptics.
Sun Pharma makes tender offer to acquire InSite VisionSun Pharmaceutical Industries has made a tender offer to acquire US-based eyecare firm InSite Vision for USD 0.35 per share in cash.
Titan scouts for tech partner for its smart-watch"We are looking for a technology partner and we aim to bring out a watch in a year's time. It will be a utility watch," Titan Company manag...
Titan has 60-65 per cent market share in wrist watch segment"Titan commands a market share of 60-65 per cent in wrist watch segment," company's Associate Vice President and Business Head (West) K S G...
Allergan Inc eyes Rs 1,000 crore in revenues from India by 2017-18"Our dream is to touch Rs 1,000 crore revenue figure by 2017-18. We are on track to get it on the back of what we have created here."
Young buyers drive 'lipstick' sales as slowdown gets sharperThe colour cosmetics market, according to industry data, in India is estimated to be Rs 1,600 crore, growing at a CAGR of 8% over the last ...
- Wellness market may touch $20 billion in next 3-4 yrs
Currently the size of the wellness market in India stood at about $ 10 billion, Allergan India Managing Director Raghu Kumar said.
- Bausch & Lomb enters Pharmaceutical market
Eyecare firm Bausch & Lomb has entered into a drug supply deal with Bangalore-based Micro Labs, marking its entry into the country’s pharma...
- GrandVision co eyes pact with Reliance for India debut
Vision Express, part of Europe’s largest optical retail group GrandVision, is in talks with Reliance Retail for an exclusive distribution a...
- Bausch & Lomb plans pharma foray
Bausch & Lomb plans to enter the ophthalmic pharmaceutical market in India. As of now, its Indian subsidiary is engaged in two product line...